Equity Profile

GRDN

Guardian Pharmacy Services, Inc.

Health CareHealth Care Services$2.4B

Aug10Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, providing pharmacy services primarily to long-term care facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

$0.32

Revenue

Revenue growth reflects the company's ability to expand its services and customer base in a competitive market.

$366M

Wall Street expectations, options signals, track record, and call prep available with Pro.

GRDN Q2-2026 Earnings Preview

Context

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, providing pharmacy services primarily to long-term care facilities. As the demand for health care services continues to grow, especially among aging populations, Guardian plays a crucial role in ensuring that patients receive the medications they need efficiently and safely.

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+28.09%

Avg Stock Reaction

+0.16%

Last Quarter Recap

In Q1-2026, Guardian reported an EPS of $0.29, exceeding expectations by 31.82%. However, the stock saw a slight decline of 1.77% the following day, indicating mixed investor sentiment despite the positive earnings surprise.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Guardian to continue its trend of beating earnings estimates, with a consensus EPS of $0.32 for Q2-2026. The company has a strong track record of surprises, which may lead to optimistic investor sentiment.

Bull Case

If Guardian can deliver an EPS above the consensus, it could reinforce confidence in its growth strategy and lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects and negatively impact the stock.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.32

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue

$366M

Revenue growth reflects the company's ability to expand its services and customer base in a competitive market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Guardian's EPS exceed the consensus estimate of $0.32?

A beat could reinforce the company's growth narrative and positively influence investor sentiment.

What insights will management provide regarding revenue growth trends?

Understanding revenue drivers is crucial for assessing the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Guardian's ability to leverage its existing customer base for revenue growth, especially in light of recent operational improvements.

Supporting Evidence

Guardian has consistently beaten EPS estimates, indicating stronger-than-expected operational performance.

The options market is pricing a larger move than historical averages, suggesting heightened investor anticipation.

The company's focus on long-term care facilities positions it well to capture increasing demand in the health care sector.

Key Risk

If revenue growth exceeds $370M, it could challenge the current market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will determine if Guardian can sustain its growth trajectory amid increasing competition in health care services.

Bull Confirmed If

An EPS of $0.34 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $0.29 would signal potential challenges in maintaining profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±11.48%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±11.5% while GRDN has averaged ±1.5% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

25.9%

Calls (3K)P/C Ratio: 1.00Puts (300)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Guardian beats expectations, history suggests the stock could rise by around 0.16% on the following day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop of around 1.48%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new customer acquisitions or partnerships.
2Insights into cost management strategies and their impact on margins.
3Details on regulatory changes affecting the health care services sector.
4Management's outlook on market conditions and competitive landscape.
5Any commentary on technology investments and their expected returns.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Tempus AI, Inc.

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, providing pharmacy services primarily to long-term care facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

$0.32

Revenue

Revenue growth reflects the company's ability to expand its services and customer base in a competitive market.

$366M

Wall Street expectations, options signals, track record, and call prep available with Pro.

GRDN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+28.09%

Avg Stock Reaction

+0.16%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Guardian can deliver an EPS above the consensus, it could reinforce confidence in its growth strategy and lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects and negatively impact the stock.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.32

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue

$366M

Revenue growth reflects the company's ability to expand its services and customer base in a competitive market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Guardian's EPS exceed the consensus estimate of $0.32?

A beat could reinforce the company's growth narrative and positively influence investor sentiment.

What insights will management provide regarding revenue growth trends?

Understanding revenue drivers is crucial for assessing the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Guardian's ability to leverage its existing customer base for revenue growth, especially in light of recent operational improvements.

Supporting Evidence

Guardian has consistently beaten EPS estimates, indicating stronger-than-expected operational performance.

The options market is pricing a larger move than historical averages, suggesting heightened investor anticipation.

The company's focus on long-term care facilities positions it well to capture increasing demand in the health care sector.

Key Risk

If revenue growth exceeds $370M, it could challenge the current market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will determine if Guardian can sustain its growth trajectory amid increasing competition in health care services.

Bull Confirmed If

An EPS of $0.34 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $0.29 would signal potential challenges in maintaining profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±11.48%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±11.5% while GRDN has averaged ±1.5% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

25.9%

Calls (3K)P/C Ratio: 1.00Puts (300)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Guardian beats expectations, history suggests the stock could rise by around 0.16% on the following day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop of around 1.48%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new customer acquisitions or partnerships.
2Insights into cost management strategies and their impact on margins.
3Details on regulatory changes affecting the health care services sector.
4Management's outlook on market conditions and competitive landscape.
5Any commentary on technology investments and their expected returns.